We have located links that may give you full text access.
Cardiorespiratory Fitness, Lung Cancer Incidence, and Cancer Mortality in Male Smokers.
American Journal of Preventive Medicine 2019 November
INTRODUCTION: The preventive role of cardiorespiratory fitness in lung cancer among smokers is unknown. This study aims to evaluate the association between cardiorespiratory fitness and lung cancer incidence and cancer mortality in former and current male smokers.
METHODS: From 1987 to 2014, cardiorespiratory fitness (quantified from treadmill exercise testing) was assessed in 2,979 men (former smokers, n=1,602; current smokers, n=1,377) aged 59.1 (SD=17.4) years and prospectively followed up for 11.6 (SD=7) years. Multivariable Cox hazard models and population attributable fraction of low cardiorespiratory fitness (<5 METs) for cancer outcomes were analyzed during 2018.
RESULTS: Of the 99 case patients diagnosed with lung cancer, 79 died of cancer 3.6 (SD=4.6) years after diagnosis. Among former smokers, 1-MET increase and categories of moderate and high cardiorespiratory fitness were associated with 13% (p=0.016), 51%, and 77% (p-trend=0.015) reductions in lung cancer incidence, respectively. Among current smokers who were later diagnosed with lung cancer, 1-MET increase and categories of moderate and high cardiorespiratory fitness were associated with 18% (p=0.008), 84%, and 85% (p-trend<0.001) reductions in cancer mortality, respectively. The population attributable fraction for lung cancer incidence was 10.8% among former smokers and 22.3% for cancer mortality among current smokers.
CONCLUSIONS: Higher cardiorespiratory fitness is associated with lower risk of lung cancer incidence in former smokers and reduced risk of cancer mortality in current smokers who were diagnosed with lung cancer. Screening for low cardiorespiratory fitness and achieving at least moderate cardiorespiratory fitness could potentially reduce lung cancer morbidity and mortality, providing a preventive strategy for smokers.
METHODS: From 1987 to 2014, cardiorespiratory fitness (quantified from treadmill exercise testing) was assessed in 2,979 men (former smokers, n=1,602; current smokers, n=1,377) aged 59.1 (SD=17.4) years and prospectively followed up for 11.6 (SD=7) years. Multivariable Cox hazard models and population attributable fraction of low cardiorespiratory fitness (<5 METs) for cancer outcomes were analyzed during 2018.
RESULTS: Of the 99 case patients diagnosed with lung cancer, 79 died of cancer 3.6 (SD=4.6) years after diagnosis. Among former smokers, 1-MET increase and categories of moderate and high cardiorespiratory fitness were associated with 13% (p=0.016), 51%, and 77% (p-trend=0.015) reductions in lung cancer incidence, respectively. Among current smokers who were later diagnosed with lung cancer, 1-MET increase and categories of moderate and high cardiorespiratory fitness were associated with 18% (p=0.008), 84%, and 85% (p-trend<0.001) reductions in cancer mortality, respectively. The population attributable fraction for lung cancer incidence was 10.8% among former smokers and 22.3% for cancer mortality among current smokers.
CONCLUSIONS: Higher cardiorespiratory fitness is associated with lower risk of lung cancer incidence in former smokers and reduced risk of cancer mortality in current smokers who were diagnosed with lung cancer. Screening for low cardiorespiratory fitness and achieving at least moderate cardiorespiratory fitness could potentially reduce lung cancer morbidity and mortality, providing a preventive strategy for smokers.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app